☰

Lilian Ng - Publications

Affiliations: 
University of Wisconsin-Milwaukee, Milwaukee, WI 
Area:
Finance, Accounting Business Administration
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Cheung PF, Yip CW, Ng LW, Lo KW, Chow C, Chan KF, Cheung TT, Cheung ST. Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line. Cancer Cell International. 16: 41. PMID 27279800 DOI: 10.1186/s12935-016-0322-5  0.55
2016 Cheung PF, Cheung TT, Yip CW, Ng LW, Fung SW, Lo CM, Fan ST, Cheung ST. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma. Oncotarget. PMID 26942873 DOI: 10.18632/oncotarget.7803  0.745
2015 Ardakani NM, Lum D, Ng L, Kumarasinghe MP. Giant cell tumour of the gallbladder can mimic undifferentiated/anaplastic carcinoma clinically and pathologically. Pathology. 47: 698-702. PMID 26517636 DOI: 10.1097/PAT.0000000000000341  0.351
2015 Chow AK, Yau TC, Ng L, Chu AC, Law WL, Poon RT, Pang RW. A preclinical study on the combination therapy of everolimus and transarterial chemoembolization in hepatocellular carcinoma. American Journal of Cancer Research. 5: 2376-86. PMID 26396913  0.531
2015 Cheung PF, Yip CW, Ng LW, Wong CK, Cheung TT, Lo CM, Fan ST, Cheung ST. Restoration of natural killer activity in hepatocellular carcinoma by treatment with antibody against granulin-epithelin precursor. Oncoimmunology. 4: e1016706. PMID 26140244 DOI: 10.1080/2162402X.2015.1016706  0.756
2014 Cheung PF, Yip CW, Ng LW, Lo KW, Wong N, Choy KW, Chow C, Chan KF, Cheung TT, Poon RT, Fan ST, Cheung ST. Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo. Cancer Cell International. 14: 103. PMID 25349534 DOI: 10.1186/S12935-014-0103-Y  0.749
2014 Cheung PF, Yip CW, Wong NC, Fong DY, Ng LW, Wan AM, Wong CK, Cheung TT, Ng IO, Poon RT, Fan ST, Cheung ST. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity. Cancer Immunology Research. 2: 1209-19. PMID 25315249 DOI: 10.1158/2326-6066.CIR-14-0096  0.746
2014 Or YY, Chow AK, Ng L, Fan ST, Yau TC, Poon RT, Pang RW. Survivin depletion inhibits tumor growth and enhances chemosensitivity in hepatocellular carcinoma. Molecular Medicine Reports. 10: 2025-30. PMID 25070628 DOI: 10.3892/mmr.2014.2413  0.757
2012 Chow AK, Ng L, Sing Li H, Cheng CW, Lam CS, Yau TC, Cheng PN, Fan ST, Poon RT, Pang RW. Anti-tumor efficacy of a recombinant human arginase in human hepatocellular carcinoma. Current Cancer Drug Targets. 12: 1233-43. PMID 22873218  0.732
Show low-probability matches.